MDACC — Houston, Texas

MDACC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

MDACC has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma.

Sponsors: Sumitomo Pharma America, Inc., Agenus Inc., Vividion Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MDACC?

MDACC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MDACC conducted?

MDACC has 9 clinical trials on record, with 5 currently active. Their work covers Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma.

Is MDACC accredited by Crixeo Health?

Yes — MDACC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MDACC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.